R120 PRIA Fee Category
PRIA 4 Fee Determination Decision Tree:
Conventional New Registration - New AI - Indoor Non-Food Use
Below is the fee for your selected Fee Category for Fiscal Years 2020-2021
|Action Code||Description||FY'20-FY'21 Fee||Decision Time (months)|
|R120||New Active Ingredient, Non-food use; indoor; reduced risk (2) (3)||$254,620||14|
Do you plan to request either of the following types of waivers?
|50% waiver||You pay ---->>>>>||$127,310|
|75% waiver||You pay ---->>>>>||$63,655|
To pay the fee shown above, go to Paying PRIA Application Fees web page and follow the instructions.
How to submit your application directly to EPA.
|Action Code Interpretation|
An application that proposes a non-food use for an active ingredient that is not currently contained as an active ingredient in any U.S. registered pesticide product. A non-food use includes a proposed use that is not a food use as described in the food use categories. Indoor means that the proposed use is for use inside of manmade structures. All indoor non-food uses included in the application are covered by the base fee for the application in this category if submitted simultaneously. Some examples of indoor uses are termiticide structural protection and indoor residential treatments (i.e. cockroach treatments).
Treatment of ornamentals in a shade house is classified as outdoor uses and is not covered in this category.
A “reduced risk” (https://19january2021snapshot.epa.gov/pesticide-registration/conventional-reduced-risk-pesticide-program) submission must accompany the application for registration. The Agency’s Reduced Risk Committee will evaluate the submission and make the determination, based on criteria and guidance listed in PR Notice 97-3 and in FIFRA 3(c )(10) (B) (-iv), whether the requested use(s) qualify as “reduced risk” when compared to currently registered pesticides for the same use(s). The reduced risk status of any use of a chemical is an initial assessment. Should information warrant, or should the Agency determine at any time that the data base for the chemical is unacceptable or upon a more thorough review found to be insufficient to demonstrate that the use/application is reduced risk, the Agency may reject reduced risk status. In the event that any uses do not qualify as “reduced risk” by decision of the Reduced Risk Committee, the application will not receive the reduced risk decision timeframes. The fee category will be changed to the category R110 and the action will receive the R110 decision review timeframe.
All of the inerts used in the product must be either approved, pending with the Agency, or a new inert is submitted within the package for the applicable uses.
A maximum of five new products are covered by the base fee. After the first five new products, each application for an additional new product or new inert ingredient approval that is submitted within this new active ingredient package is subject to the registration service fee for a new product or a new inert ingredient approval. All such associated applications that are submitted together will be subject to the new active ingredient decision review time.
Until the new active ingredient is approved, any subsequent application for another new product containing the same active ingredient or an amendment to the proposed labeling will be charged a new active ingredient service fee and decision review timeframe.
If the applicant on his own initiative submits any additional information that was neither requested nor required by the Agency, after completion of the technical deficiency screening, and which does not itself constitute a covered registration application, the applicant will be charged an additional 25% of the full registration service fee for the new active ingredient application.
The Agency will provide the applicant with a pre-decisional determination 4 weeks prior to the PRIA decision review time due date which specifies any label changes that have to be made in order to grant the requested new active ingredient registration. If the label issues cannot be resolved prior to the PRIA decision review time due date and if a PRIA due date time extension has not been agreed upon, then the Agency will issue to the applicant its regulatory decision with the specific label changes and supporting documentation on or just before the PRIA decision review time due date. At that time the applicant must either (a) agree to all of the label changes and submit a revised label that incorporates all of these label changes; or (b) does not agree with one or more of the label changes and request up to 30 days to reach agreement with the Agency and submit a revised label that incorporates all of the agreed upon label changes, which the Agency has 2 business days to review; or (c) withdraw the application without prejudice.